NCT06738810View on ClinicalTrials.gov

: Identification of Non-alcoholic Steato-hepatitis Cases in a Sample of Type 2 Diabetes Patients, with a Disruption of the Liver Function Tests, At the Pointe-à-Pitre University Hospital

NACompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

June 21, 2018

Primary Completion Date

February 1, 2022

Study Completion Date

February 1, 2022

Conditions
Non-alcoholic Steato-hepatitis
Interventions
DIAGNOSTIC_TEST

Fibrotest-actitest/NASHtest

A blood sample will be collected from the patient in order to do Fibrotest-actitest/NASHtest and to calculate the NAFLD fibrosis score

Trial Locations (1)

97159

CHU de la Guadeloupe, Pointe-à-Pitre

All Listed Sponsors
lead

Centre Hospitalier Universitaire de la Guadeloupe

OTHER

NCT06738810 - : Identification of Non-alcoholic Steato-hepatitis Cases in a Sample of Type 2 Diabetes Patients, with a Disruption of the Liver Function Tests, At the Pointe-à-Pitre University Hospital | Biotech Hunter | Biotech Hunter